Global Development Lead (GDL) , Clinical Development – Lung Cancer

Revolution Medicines is a late-stage clinical oncology company seeking an experienced oncology drug-development leader to serve as Global Development Lead (GDL) for one of its most advanced clinical programs.

Requirements

• MD (or international equivalent) with board certification in Medical Oncology or Hematology/Oncology
• Recognized expertise in NSCLC developed through academic clinical leadership and/or substantial industry experience
• 13 years in oncology clinical development
• Leadership of global, late-stage development programs
• Regulatory strategy experience
• Experience with pivotal Phase 2/3 studies
• Ability to communicate complex scientific and clinical concepts clearly to executives, cross-functional partners, and external experts
• Ability to travel approximately 25–30%
• Exposure to cross-program or portfolio-level development strategy and governance

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities